2007
DOI: 10.1007/s00018-007-7051-9
|View full text |Cite
|
Sign up to set email alerts
|

Caffeine analogs: biomedical impact

Abstract: Caffeine, widely consumed in beverages, and many xanthine analogs have had a major impact on biomedical research. Caffeine and various analogs, the latter designed to enhance potency and selectivity toward specific biological targets, have played key roles in defining the nature and role of adenosine receptors, phosphodiesterases, and calcium release channels in physiological processes. Such xanthines and other caffeine-inspired heterocycles now provide important research tools and potential therapeutic agents… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

2
232
0
4

Year Published

2009
2009
2024
2024

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 232 publications
(238 citation statements)
references
References 152 publications
2
232
0
4
Order By: Relevance
“…Caffeine modulates CNS activities through several mechanisms of action including antagonism of adenosine and GABA A receptors (Daly 2007), phosphodiesterase inhibition (Smellie et al 1979) and sensitization of calcium‐induced calcium release through ryanodine‐sensitive channels (McPherson et al 1991; Martín & Buño 2003). It has been suggested that, at the concentration typically consumed by humans, caffeine may act mainly by inhibiting adenosine receptors in the CNS (Fredholm 1995).…”
Section: Introductionmentioning
confidence: 99%
“…Caffeine modulates CNS activities through several mechanisms of action including antagonism of adenosine and GABA A receptors (Daly 2007), phosphodiesterase inhibition (Smellie et al 1979) and sensitization of calcium‐induced calcium release through ryanodine‐sensitive channels (McPherson et al 1991; Martín & Buño 2003). It has been suggested that, at the concentration typically consumed by humans, caffeine may act mainly by inhibiting adenosine receptors in the CNS (Fredholm 1995).…”
Section: Introductionmentioning
confidence: 99%
“…Caffeine has been used in pharmaceutical preparations as a neurological, cardiac and respiratory stimulant. It is also used as an analgesic enhancer in cold, cough and headache medicines (Daly, 2007). Other pharmaceutical applications of methylxanthines include use as a diuretic and a bronchodilator, and for relief of bronchial spasms and control of asthma (Daly, 2007).…”
Section: Introductionmentioning
confidence: 99%
“…It is also used as an analgesic enhancer in cold, cough and headache medicines (Daly, 2007). Other pharmaceutical applications of methylxanthines include use as a diuretic and a bronchodilator, and for relief of bronchial spasms and control of asthma (Daly, 2007). 1-Methylxanthine, 1-methyluric acid and uric acid have also been studied for their antioxidant properties (Lee, 2000).…”
Section: Introductionmentioning
confidence: 99%
“…9,31,32 In most cases, the drug treatment raises the level of endogenous cAMP by blocking its hydorolysis, 32 and causes an imbalance of cAMP-signaling pathways involving G proteins and protein kinases. 33 This results in a serious alteration of physiological function.…”
Section: Discussionmentioning
confidence: 99%